This company develops microbial ecosystems for health using a full-stack technology platform for microbiome drug discovery. Their spatial mapping engine visualizes host-microbiome interactions to generate therapeutic insights. Integrated in-house manufacturing translates these findings into scalable, clinical-stage live biotherapeutic products designed to modulate host immunity.
Funding
$24.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
LCFounders
Product
Problem
Understanding the complex interactions between the host and microbiome is a significant challenge in therapeutic development. Current methods lack the ability to visualize and analyze these spatial relationships effectively, hindering the development of targeted microbiome-based therapies.
Solution
This startup offers a spatial mapping discovery engine that visualizes host-microbiome interactions, providing insights for therapeutic development and a deeper understanding of microbiome dynamics. The technology platform provides detailed visualizations of the interactions and connections between the host and the microbiome. By illuminating the spatial biology of the host-microbiome interface, the platform enables the identification of new opportunities for effective therapeutic interventions, ultimately improving patient outcomes.
Target Audience
The primary target audience includes researchers and pharmaceutical companies involved in microbiome-based therapeutic development.
Features
- Spatial mapping technology to visualize host-microbiome interactions in situ.
- Full-stack technology platform for microbiome drug discovery.